Early Toxicity Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Early Toxicity Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • June 2022 •
  • 142 pages •
  • Report ID: 6287771 •
  • Format: PDF
The global early toxicity testing market reached a value of US$ 1.08 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 1.79 Billion by 2027, exhibiting a CAGR of 8.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Early toxicity testing of new compounds is used to develop drugs and the extension of the therapeutic potential of existing molecules. It is carried out at pre-clinical stages on various biological systems to investigate the species, organs, and dose-specific toxic effects of a product. It can be performed in multiple ways, including in vivo on animals, in vitro in laboratories using assays, and in silico on a computer. It is also utilized for studying accidental exposures to a substance. Nowadays, the high-cost impact of late-stage failures of drug candidates is encouraging pharma companies to conduct early toxicity testing on investigational products.

Early Toxicity Testing Market Trends:
Exposure to toxic chemicals occurs through skin contact, oral intake, or inhalation. Therefore, early toxicity testing has become a crucial process in various industrial applications for determining the degree of toxicity in products and ensuring that they are safe for human consumption and the environment. For example, it is extensively utilized in the food and beverage (F&B) industry to identify the adverse effects and characterize potential toxicants in products. Moreover, the rising prevalence of diseases and the requirement of novel drugs and biological products are encouraging the adoption of early toxicity testing to prevent the failure of candidate drugs at clinical trials. In addition, stringent regulations relating to public health welfare imposed by regulatory authorities are positively influencing the demand for early toxicity testing to determine the viability of drugs required for regulatory approval. Apart from this, the increasing usage of pesticides can pose risks to human health, which is promoting the use of early toxicity testing in the agriculture industry. Furthermore, the escalating demand for cosmetic products is expanding the application of early toxicity testing of cosmetic ingredients worldwide.

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global early toxicity testing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technique and end user.

Breakup by Technique:
In Vivo
In Vitro
In Silico

Breakup by End User:
Pharmaceuticals Industry
Food Industry
Chemicals Industry
Cosmetics Industry

Breakup by Region:
North America
United States
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Enzo Biochem Inc., Eurofins Scientific SE, Evotec A.G., Merck KGaA, PerkinElmer Inc., SGS S.A., Thermo Fisher Scientific Inc. and WuXi AppTec.

Key Questions Answered in This Report:

How has the global early toxicity testing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global early toxicity testing market?
What are the key regional markets?
What is the breakup of the market based on the technique?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global early toxicity testing market and who are the key players?
What is the degree of competition in the industry?